Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future PerspectivesDavide Fiore Bavaro, Annalisa Saracino, Alessandra Belati et al.|Antibiotics|2021Cited by 95
Effectiveness of First-Line Therapy with Old and Novel Antibiotics in Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter baumannii: A Real Life, Prospective, Observational, Single-Center StudyLidia Dalfino, Salvatore Grasso, Davide Fiore Bavaro et al.|Antibiotics|2023Cited by 32
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort StudyDavide Fiore Bavaro, Annalisa Saracino, Roberta Papagni et al.|Infectious Diseases and Therapy|2023Cited by 29
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort studyDavide Fiore Bavaro, Annalisa Saracino, Alessandra Belati et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 13
First Case of Candida Auris Sepsis in Southern Italy: Antifungal Susceptibility and Genomic Characterisation of a Difficult-to-Treat Emerging YeastStefania Stolfa, Maria Chironna, Luigi Ronga et al.|Microorganisms|2024Cited by 4